Fmoc-D-Norleucine

Fmoc-D-Norleucine is a D-configured, Fmoc-protected norleucine amino acid derivative that functions as a chiral building block for peptide chemistry. The molecule contains an Fmoc carbamate on the amino group, a free carboxylic acid for coupling, and a straight-chain aliphatic side chain that lacks heteroatoms and aromatic rings, which influences hydrophobicity and conformational behavior in peptide sequences. The stereogenic center at the α-carbon is fixed in the D-configuration, enabling stereochemically defined incorporation into peptide analogs and chiral synthetic sequences. The Fmoc protecting group supports standard base-labile deprotection, while the carboxylic acid participates in amide bond formation under peptide coupling conditions, making the compound suitable for downstream derivatization and synthetic intermediate use.

1. Peptide Synthesis

Fmoc-D-Norleucine is used in solid-phase peptide synthesis and solution-phase peptide coupling where a D-amino acid residue is required to tune proteolytic stability and stereochemical patterning. The Fmoc-protected amine and free carboxylic acid enable formation of peptide bonds via standard coupling chemistries after orthogonal deprotection, while the D-configuration preserves sequence-defined chirality in the growing chain. The unbranched norleucine side chain provides a hydrophobic, flexible segment that can modulate folding propensity, aggregation behavior, and membrane-interaction tendencies in peptide scaffolds. Incorporation into peptide building block libraries supports systematic peptide construction for structure-activity relationship studies and peptidomimetic design.

2. Peptidomimetics And SAR

Fmoc-D-Norleucine is applied in peptidomimetic construction and SAR studies where side-chain hydrophobicity and backbone stereochemistry are tuned to probe molecular recognition. The aliphatic side chain and D-α-amino acid stereochemistry can be leveraged to generate analog series that alter conformational preferences without introducing additional functional groups that might confound interpretation. Fmoc protection supports iterative assembly of peptide analogs, and subsequent deprotection yields a residue-compatible intermediate for further functionalization or conjugation. The resulting D-norleucine-containing peptides and peptide analogs can be used as chemically defined tools for mapping structure-function relationships in biomolecular binding assays.

3. Chiral Building Block Synthesis

Fmoc-D-Norleucine is suitable as a chiral amino acid intermediate for stereoselective synthesis of D-configured fragments used in medicinal chemistry and fine chemical production. The fixed D stereocenter and protected amino functionality allow incorporation into larger chiral frameworks while maintaining control over epimerization-sensitive steps through Fmoc-based protection and deprotection cycles. The carboxylic acid enables conversion into activated derivatives for downstream amide formation, supporting preparation of chiral amide-containing intermediates beyond peptide contexts. The compound can therefore serve as a practical input for chiral synthesis routes that require a D-amino acid motif with a hydrophobic, straight-chain side chain.

4. Chemical Biology Tooling

Fmoc-D-Norleucine is utilized in chemical biology research to generate stereochemically defined peptide probes and biomolecule-interaction reagents. The Fmoc-protected amino group supports controlled incorporation into peptide tags, while the D-configuration can improve resistance to enzymatic degradation in probe constructs that include protease-sensitive sequences. The carboxylic acid functionality enables conversion into coupling-ready forms for attaching affinity handles, linkers, or reporter moieties during probe synthesis workflows. The hydrophobic norleucine side chain can also support membrane-association or binding-site occupancy in peptide-based probes used for mechanistic studies and molecular recognition mapping.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-Norleucine is relevant to pharmaceutical intermediate preparation where D-amino acid motifs are incorporated into peptide-like or peptidomimetic chemotypes during process development. The Fmoc carbamate provides a robust protection strategy compatible with manufacturing-oriented peptide assembly workflows, while the free carboxylic acid supports conversion into coupling intermediates for amide bond formation in larger synthetic sequences. The absence of reactive side-chain heteroatoms reduces competing functional group chemistry, which can simplify purification and downstream transformations when producing protected amino acid derivatives for scale-up. The compound thus functions as a stereochemically defined building block for generating D-norleucine-containing intermediates used in industrial fine chemical synthesis and applied peptide analog production.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications